Mar 18, 2021 | Uncategorized
Am Forschungsstandort Potsdam Golm haben die Wissenschaftler Frank Sellrie und Jörg Schenk von der Arbeitsgruppe Immuntechnologie der UP Transfer GmbH an der Universität Potsdam Antikörper zum Nachweis des Coronavirus SARS-CoV-2 entwickelt. Auf Grundlage dieser neuen...
Mar 4, 2021 | Uncategorized
As the New Year of the Ox promises to bring prosperity and happiness, InVivo would like to grasp the golden opportunity in building new collaborations in East Asia! We are looking forward to two exciting events that will take place in March: a digital business trip...
Nov 2, 2020 | Uncategorized
Festival of Biologics (2-6 November 2020) is approaching fast and we would like to update you on our participation this year. We will be showcasing a talk by Dr. Christian Scherling, Business Development Manger EU & USA about InVivo´s new approach for stable cell...
Apr 28, 2020 | Uncategorized
InVivo now offers recombinant antigens for Corona virus / COVID-19 in vitro diagnostics. Using transient gene expression in HEK cells, InVivo successfully produces different surface glycoprotein (S) variants. These include the SARS-CoV-2 Receptor Binding Domain (RBD)...
Mar 26, 2020 | Uncategorized
Dear Visitor, despite the current Coronavirus/COVID-19 events our production sites in Hennigsdorf and Berlin are fully operational. We have taken all necessary precautions to protect and maintain the health of our employees, while processing your orders reliably and...
